Expression of cytokine- and chemokine-related genes in peripheral blood mononuclear cells from lupus patients by cDNA array

Clinical Immunology

Volumn 102, Issue 3, 2002, Pages 283-290

  Rus, Violeta ^a   Atamas, Sergei P ^a   Shustova, Valentina ^a   Luzina, Irina G ^a   Selaru, Florin ^a   Magder, Laurence S ^a   Via, Charles S ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

CDNA arrays; Chemokines; Cytokines; Systemic lupus erythematosus

Indexed keywords

CHEMOKINE; COMPLEMENTARY DNA; CYTOKINE; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 8; INTERLEUKIN 8 RECEPTOR; MOLECULAR MARKER; TUMOR NECROSIS FACTOR RECEPTOR;

ADULT; ARTICLE; CLINICAL ARTICLE; CLUSTER ANALYSIS; CONTROLLED STUDY; DNA DETERMINATION; DNA HYBRIDIZATION; DNA MICROARRAY; FEMALE; GENE EXPRESSION; GENE IDENTIFICATION; HUMAN; MALE; MONONUCLEAR CELL; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SYSTEMIC LUPUS ERYTHEMATOSUS; TECHNIQUE;

EID: 0036201362     PISSN: 15216616     EISSN: None     Source Type: Journal    
DOI: 10.1006/clim.2001.5182     Document Type: Article

References (44)

1. Overview of cellular immune function in systemic lupus erythematosus
2. Analysis of gene expression profiles in normal and neoplastic ovarian tissue samples identifies candidate molecular markers of epithelial ovarian cancer
3. Broad patterns of gene expression revealed by clustering analysis of tumor and normal colon tissues probed by oligonucleotide arrays
4. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
5. Molecular portraits of human breast tumours
6. Apoptosis signals in atopy and asthma measured with cDNA arrays
7. Discovery and analysis of inflammatory disease-related genes using cDNA microarrays
8. Analysis of gene expression in mutiple sclerosis lesions using cDNA microarrays
9. The 1982 revised criteria for the classification of systemic lupus erythematosus
10. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE
11. Significance analysis of microarrays applied to the ionizing radiation response
12. Cluster analysis and display of genome-wide expression patterns
13. Low levels of interleukin-1 receptor antagonist coincide with kidney involvement in systemic lupus erythematosus
14. Serum IL-6, TNFalpha, p55 srTNFalpha, p75srTNFalpha, srIL-2alpha levels and disease activity in systemic lupus erythematosus
15. Circulating levels of tumor necrosis factor soluble receptors in systemic lupus erythematosus are significantly higher than in other rheumatic diseases and correlate with disease activity
16. Increased serum stromelysin-1 levels in systemic lupus erythematosus: Lack of correlation with disease activity
17. Correlations of monocyte phagocytic receptor expressions with serum immune complex level in systemic lupus erythematosus
18. Spontaneous production of bone-resorbing lymphokines by B cells in patients with systemic lupus erythematosus
19. Production of intracellular and extracellular interleukin-1 alpha and interleukin-1 beta by peripheral blood monocytes from patients with connective tissue diseases
20. Quantitative assessment of DNA microarrays - Comparison with Northern blot analyses
21. Correlation between protein and mRNA abundance in yeast
22. Functional characterization of the S. cerevisiae genome by gene deletion and parallel analysis
23. TRAIL/Apo-2-ligand-induced apoptosis in human T cells
24. Inhibition of HIV infection by the cytokine midkine
25. Urokinase-type plasminogen activator enhances invasion of human T cells (Jurkat) into a fibrin matrix
26. Surface expression of TRAIL/Apo-2 ligand in activated mouse T and B cells
27. Expression of TRAIL receptors in human autoreactive and foreign antigen-specific T cells
28. Chemokine receptor expressions and responsiveness of cord blood T cells
29. Preliminary criteria for the classification of systemic lupus erythematosus
30. CCR7 expression and memory T cell diversity in humans
31. Roles of TNF-related apoptosis-inducing ligand in experimental autoimmune encephalomyelitis
32. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is an inhibitor of autoimmune inflammation and cell cycle progression
33. Measurement of systemic lupus erythematosus activity in clinical research
34. Effects of IL-1 receptor accessory protein on IL-1 binding
35. Induction of functional IL-8 receptors by IL-4 and IL-13 in human monocytes
36. Combinatorial model of chemokine involvement in glomerular monocyte recruitment: Role of CXC chemokine receptor 2 in infiltration during nephrotoxic nephritis
37. MCP-1 and IL-8 trigger firm adhesion of monocytes to vascular endothelium under flow conditions
38. Recombinant human granulocyte colony stimulating factor in patients with systemic lupus erythematosus associated neutropenia and refractory infections
39. Pharmacological doses of granulocyte colony-stimulating factor affect cytokine production by lymphocytes in vitro and in vivo
40. Decreased production of TGF-beta by lymphocytes from patients with systemic lupus erythematosus
41. Cooperation among Stat1, glucocorticoid receptor, and PU.1 in transcriptional activation of the high-affinity Fc gamma receptor I in monocytes
42. The combination of endotoxin and dexamethasone induces type II interleukin 1 receptor (IL-1r II) in monocytes: A comparison to interleukin 1 beta (IL-1 beta) and interleukin 1 receptor antagonist (IL-1ra)
43. Expression of interleukin-16 by human epithelial cells. Inhibition by dexamethasone
44. Expression of IL-16 in allergen-induced late-phase nasal responses and relation to topical glucocorticosteroid treatment